These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38771048)

  • 61. CXCR2 antagonist for patients with chronic obstructive pulmonary disease with chronic mucus hypersecretion: a phase 2b trial.
    Lazaar AL; Miller BE; Donald AC; Keeley T; Ambery C; Russell J; Watz H; Tal-Singer R;
    Respir Res; 2020 Jun; 21(1):149. PubMed ID: 32532258
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Chronic obstructive pulmonary disease mortality, a competing risk analysis.
    Abukhalaf J; Davidson R; Villalobos N; Meek P; Petersen H; Sood A; Tesfaigzi Y; Vazquez Guillamet R
    Clin Respir J; 2018 Nov; 12(11):2598-2605. PubMed ID: 30257066
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Mucus Plugs and Small Airway Dysfunction in Asthma, COPD, and Asthma-COPD Overlap.
    Tamura K; Shirai T; Hirai K; Nakayasu H; Takahashi S; Kishimoto Y; Akamatsu T; Asada K; Kato S
    Allergy Asthma Immunol Res; 2022 Mar; 14(2):196-209. PubMed ID: 35255537
    [TBL] [Abstract][Full Text] [Related]  

  • 64. New drugs offer a lifeline for COPD and other respiratory diseases. Mucus-blocking medications could save countless lives.
    Duke Med Health News; 2013 Feb; 19(2):3. PubMed ID: 23495419
    [No Abstract]   [Full Text] [Related]  

  • 65. Expression of airway mucus-associated proteins in rats with chronic obstructive pulmonary disease with a cold-dryness symptom pattern.
    Gao Z; Halmurat U; Wang J; Jing J; Li Z; Xu D; Li F
    J Tradit Chin Med; 2016 Oct; 36(5):671-7. PubMed ID: 29949317
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Multiple dosing of simvastatin inhibits airway mucus production of epithelial cells: implications in the treatment of chronic obstructive airway pathologies.
    Marin L; Traini D; Bebawy M; Colombo P; Buttini F; Haghi M; Ong HX; Young P
    Eur J Pharm Biopharm; 2013 Aug; 84(3):566-72. PubMed ID: 23474382
    [TBL] [Abstract][Full Text] [Related]  

  • 67. CLCA1 and TMEM16A: the link towards a potential cure for airway diseases.
    Brett TJ
    Expert Rev Respir Med; 2015 Oct; 9(5):503-6. PubMed ID: 26296094
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Prognostic impact of chronic obstructive pulmonary disease on adverse prognosis in hospitalized heart failure patients with preserved ejection fraction - A report from the JASPER registry.
    Sato Y; Yoshihisa A; Oikawa M; Nagai T; Yoshikawa T; Saito Y; Yamamoto K; Takeishi Y; Anzai T
    J Cardiol; 2019 Jun; 73(6):459-465. PubMed ID: 30718015
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Epigenetics of Mucus Hypersecretion in Chronic Respiratory Diseases.
    Saco TV; Breitzig MT; Lockey RF; Kolliputi N
    Am J Respir Cell Mol Biol; 2018 Mar; 58(3):299-309. PubMed ID: 29096066
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cause-specific mortality adjudication in the UPLIFT® COPD trial: findings and recommendations.
    McGarvey LP; Magder S; Burkhart D; Kesten S; Liu D; Manuel RC; Niewoehner DE
    Respir Med; 2012 Apr; 106(4):515-21. PubMed ID: 22100536
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cardiovascular events after clarithromycin use in lower respiratory tract infections: analysis of two prospective cohort studies.
    Schembri S; Williamson PA; Short PM; Singanayagam A; Akram A; Taylor J; Singanayagam A; Hill AT; Chalmers JD
    BMJ; 2013 Mar; 346():f1235. PubMed ID: 23525864
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Epidemiology and impact of chronic bronchitis in chronic obstructive pulmonary disease.
    Lahousse L; Seys LJM; Joos GF; Franco OH; Stricker BH; Brusselle GG
    Eur Respir J; 2017 Aug; 50(2):. PubMed ID: 28798087
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Mortality of patients with chronic obstructive pulmonary disease: a nationwide populationbased cohort study.
    Park SC; Kim DW; Park EC; Shin CS; Rhee CK; Kang YA; Kim YS
    Korean J Intern Med; 2019 Nov; 34(6):1272-1278. PubMed ID: 31610634
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Identification of Mucus-Associated Molecular Subtypes of Chronic Obstructive Pulmonary Disease: A Latent Profile Analysis Based on MUC5B-Associated Genes.
    Hu Y; Cheng X; Qiu Z; Chen X
    Med Sci Monit; 2021 Aug; 27():e931222. PubMed ID: 34389698
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Transport of mucoid mucus in healthy individuals and patients with chronic obstructive pulmonary disease and bronchiectasis].
    Lima Afonso J; Tambascio J; Dutra de Souza HC; Jardim JR; Baddini Martinez JA; Gastaldi AC
    Rev Port Pneumol; 2013; 19(5):211-6. PubMed ID: 23755998
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Chronic Obstructive Pulmonar Disease Mortality. SEPAR COPD-Smoking Year.
    de Granda-Orive JI; Solano-Reina S
    Arch Bronconeumol; 2016 Aug; 52(8):407-8. PubMed ID: 26873517
    [No Abstract]   [Full Text] [Related]  

  • 77. Trends in the mortality of chronic obstructive pulmonary disease in Taiwan, 1981-2002.
    Kuo LC; Yang PC; Kuo SH
    J Formos Med Assoc; 2005 Feb; 104(2):89-93. PubMed ID: 15765162
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Mucus hypersecretion in COPD: should we only rely on symptoms?
    Burgel PR; Martin C
    Eur Respir Rev; 2010 Jun; 19(116):94-6. PubMed ID: 20956176
    [No Abstract]   [Full Text] [Related]  

  • 79. Mucoactive drugs for asthma and COPD: any place in therapy?
    Rogers DF
    Expert Opin Investig Drugs; 2002 Jan; 11(1):15-35. PubMed ID: 11772318
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Mucus hypersecretion in respiratory disease. Chair's introduction.
    Basbaum C
    Novartis Found Symp; 2002; 248():1-2. PubMed ID: 12568484
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.